Recombinant TMEM150B is produced using expression systems such as E. coli, yeast, or mammalian cells to generate partial or full-length protein variants . Key features include:
Autophagy Regulation: Modulates autophagosome accumulation under basal conditions and enhances autophagic flux .
BMP Signaling Antagonism: Physically interacts with ALK2 to inhibit bone morphogenetic protein (BMP) signaling in Xenopus embryogenesis .
Recombinant TMEM150B is employed in diverse experimental contexts:
Commercial and academic sources provide TMEM150B reagents with varying specifications:
TMEM150B is expressed in the Spemann organizer of Xenopus embryos and is induced by Activin/Nodal signaling .
Knockdown disrupts dorsoventral patterning, highlighting its role in BMP pathway regulation .
TMEM150B overexpression increases autophagosome formation but does not alter apoptosis rates in cancer cells .
Promotes clonogenic survival under glucose deprivation independently of macroautophagy .
In mice, Tmem150b knockout does not affect oocyte maturation or spindle organization .
Human TMEM150B interacts with BRSK1 kinase and MCM8 helicase, suggesting roles in DNA repair .
Structural Limitations: Full-length structural data for X. tropicalis TMEM150B remains unavailable, necessitating homology modeling .
Functional Redundancy: Compensatory mechanisms may explain minimal phenotypes in KO models (e.g., mouse oocytes) .
Therapeutic Potential: Its role in autophagy and cell survival warrants exploration in disease models like cancer .
KEGG: xtr:548751
UniGene: Str.27389
TMEM150B (Transmembrane protein 150B), also known as Transmembrane protein 224, is a transmembrane protein found in various species including Xenopus tropicalis. The protein contains multiple transmembrane domains with the amino acid sequence including regions such as "IWIVYGMSVSNGSV..." as identified in recombinant proteins. It belongs to the DRAM (damage-regulated autophagy modulator) family, which includes five members: DRAM-1, DRAM-2, and TMEM150A/B/C . The protein's structural features enable it to span cellular membranes, which is critical for its biological functions.
TMEM150B appears to be conserved across various vertebrate species, indicating potential evolutionary importance. The protein has been identified and studied in both mammals (mice) and amphibians (Xenopus tropicalis), sharing functional domains and structural similarities . This conservation suggests that TMEM150B may have fundamental cellular functions that have been maintained throughout vertebrate evolution. Comparative studies between species can provide insights into both conserved functions and species-specific adaptations of this protein.
For optimal storage and handling of recombinant Xenopus tropicalis TMEM150B, researchers should store the protein at -20°C for regular use and at -80°C for extended storage. The protein is typically provided in a Tris-based buffer with 50% glycerol, optimized for stability . Working aliquots can be stored at 4°C for up to one week, but repeated freezing and thawing should be avoided as this may compromise protein integrity and activity . When working with the protein, it's advisable to thaw aliquots on ice and maintain cold chain management to preserve functionality.
TMEM150B knockout models can be generated using CRISPR/Cas9 technology. A successful approach documented in research involved deleting a 989 bp fragment encompassing exons 2-4 of the gene . Validation of the knockout can be performed through multiple methods:
Genotyping via PCR from genomic DNA (e.g., from mouse tails)
RT-PCR using cDNA obtained by reverse transcription of mRNA from relevant tissues
Confirmation of deletion by Sanger sequencing
Specific primers for genotyping can be designed flanking the deletion region. For example, in a mouse model study, researchers used the following primer sequences for wild type allele: F: 5′-GACTGCTTGGAGATCCAGCT-3′, R: 5′-GTGGAGGCAGTCTGACTATC-3′; and for delete allele: dF: 5′-CTTTGTGCCCTGGGTACCTC-3′, R: 5′-GTGGAGGCAGTCTGACTATC-3′ .
For effective expression analysis of TMEM150B, quantitative reverse-transcription PCR (qRT-PCR) has proven to be a reliable method. Researchers have successfully used this technique to quantify TMEM150B expression across various tissues and developmental stages . The protocol involves:
Total RNA extraction using standard methods (e.g., Qiagen RNase mini kit)
cDNA synthesis via reverse transcription
Real-time PCR using SYBR Green Master Mix with specific primers
Example primer sequences for mouse Tmem150b include: F: 5′-TTGCTGCCTGTCATCTTATTTC-3′, R: 5′-AGGTTTTGACGCCCCAGT-3′ . These should be used with an appropriate housekeeping gene control such as GAPDH. Additionally, immunofluorescence staining can be employed to visualize protein localization in cells and tissues, providing complementary data to expression studies.
TMEM150B functions as a modulator of macroautophagy, causing accumulation of autophagosomes under basal conditions and enhancing autophagic flux . As a member of the DRAM family (specifically DRAM-3), TMEM150B appears to be involved in regulating cellular degradation and recycling pathways. This role in autophagy connects to its broader function in cellular homeostasis and stress response. The protein represses cell death and promotes long-term clonogenic survival of cells , suggesting it may help cells adapt to stressful conditions by facilitating efficient autophagy.
Despite initial associations with age at natural menopause, early menopause, and premature ovarian insufficiency (POI), experimental evidence suggests TMEM150B may not be essential for female reproduction in mice. Studies using TMEM150B knockout mice showed no significant differences in:
Oocyte meiotic maturation (first polar body emission rates were similar between knockout and wild type mice)
Spindle morphology in MII stage oocytes
Follicle development and corpus luteum formation
Estrous cycling
Fertility metrics and hormonal profiles
These findings are summarized in the following data from fertility tests:
| Genotypes | Total pups | Litters/Mouse | Pups/Litter | Time to first litter (days) |
|---|---|---|---|---|
| +/+ (n=5) | 177 | 4.0 ± 0.45 | 8.85 ± 1.53 | 95 ± 3.98 |
| −/− (n=5) | 189 | 4.2 ± 0.37 | 8.59 ± 0.82 | 98 ± 6.18 |
While specific protein interaction partners for TMEM150B have not been extensively documented in the provided search results, its role in autophagy regulation suggests potential interactions with key autophagy machinery proteins. As a transmembrane protein, TMEM150B likely interacts with membrane components and possibly signaling molecules that regulate autophagosome formation and maturation . Given its classification as DRAM-3 (DRAM-related/associated member 3), it may share functional relationships with other DRAM family proteins (DRAM-1, DRAM-2, TMEM150A, and TMEM150C) . Future research employing techniques such as co-immunoprecipitation, proximity labeling, or yeast two-hybrid screening would be valuable to identify specific interaction partners.
An important consideration in TMEM150B research is the potential for functional redundancy with other DRAM family members. As noted by researchers, "TMEM150B, also named as DRAM-related/associated member 3 (DRAM-3), is one of the five members of the DRAM family which includes DRAM-1, DRAM-2 and TMEM150A/B/C" and "functional redundancy cannot be excluded" . This redundancy might explain the absence of phenotypes in TMEM150B knockout mice. Future research should consider:
Generating and characterizing double or triple knockout models targeting multiple DRAM family members
Conducting comparative expression analyses of all family members in tissues of interest
Performing rescue experiments with different family members to test functional equivalence
Using stress conditions to potentially unmask phenotypes that might be compensated under normal conditions
These approaches would help determine whether TMEM150B functions are truly dispensable or whether they are compensated by other family members.
While TMEM150B is known to modulate macroautophagy, causing accumulation of autophagosomes under basal conditions and enhancing autophagic flux , the precise molecular mechanisms remain to be fully elucidated. Advanced research could investigate:
The specific step(s) of the autophagy pathway affected by TMEM150B (initiation, elongation, fusion, or degradation)
Direct protein-protein interactions with core autophagy machinery components
Potential involvement in signaling pathways that regulate autophagy (mTOR, AMPK, etc.)
Structural determinants within TMEM150B responsible for its autophagy-modulating functions
Transcriptional or post-translational regulation of TMEM150B under various cellular conditions
Understanding these mechanisms would provide insights into both basic autophagy regulation and potential therapeutic applications targeting this pathway.
Researchers planning studies on TMEM150B should consider several important factors based on current knowledge:
Potential functional redundancy with other DRAM family members that might mask phenotypes in single gene knockout models
The importance of studying the protein under both basal and stress conditions to reveal context-dependent functions
Tissue-specific expression patterns, with particular attention to oocytes where expression is high
The dual roles in autophagy modulation and cell survival promotion
The need for appropriate model systems that recapitulate relevant aspects of human biology, especially when investigating disease associations
Additionally, researchers should be aware that despite associations with reproductive timing in humans, experimental evidence does not support an essential role for TMEM150B in female fertility in mice . This discrepancy warrants careful interpretation and potentially the use of additional model systems.
Several technological advances could significantly accelerate research on TMEM150B functions and mechanisms:
CRISPR-based screening approaches to identify genetic interactions and redundancies with other DRAM family members
Advanced imaging techniques like super-resolution microscopy to visualize TMEM150B localization and dynamics in cellular membranes
Structural biology approaches to determine the three-dimensional structure of TMEM150B and inform structure-function relationships
Single-cell transcriptomics and proteomics to characterize cell type-specific expression patterns and responses
Patient-derived organoids or iPSC models to study TMEM150B functions in human-relevant systems, particularly for disease associations
These technological approaches would help address current knowledge gaps and potentially reveal novel functions and mechanisms of this transmembrane protein.
Synthetic biology approaches offer innovative ways to study TMEM150B function:
Engineered protein variants with domain swaps between DRAM family members to identify functional domains
Optogenetic or chemogenetic control of TMEM150B activity to enable temporal precision in functional studies
Synthetic gene circuits to study TMEM150B in controlled cellular environments
Biosensors to monitor TMEM150B-dependent autophagy dynamics in real-time
Engineered cellular systems with minimal genomes to study TMEM150B function with reduced genetic complexity